Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,731 | 2,132 | 2,952 | 2,796 | 3,670 | 4,884 | 5,511 | 7,696 | 10,900 | 13,051 | | 13,615 |
% Growth | NA | 23.2% | 38.5% | -5.3% | 31.2% | 33.1% | 12.8% | 39.7% | 41.6% | 19.7% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,400) | (1,692) | (2,265) | (2,128) | (2,923) | (3,890) | (4,481) | (6,324) | (9,115) | (10,921) | | (11,342) |
Gross Profit | 330 | 440 | 687 | 668 | 747 | 994 | 1,030 | 1,372 | 1,785 | 2,130 | | 2,273 |
% Revenue | 19.1% | 20.6% | 23.3% | 23.9% | 20.4% | 20.4% | 18.7% | 17.8% | 16.4% | 16.3% | | 16.7% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (236) | (293) | (415) | (349) | (302) | (365) | (297) | (368) | (433) | (452) | | (457) |
Other Inc / (Exp) | 3 | (20) | 21 | 14 | 13 | 21 | 18 | 16 | 38 | 50 | | 31 |
Total Operating Exp | (233) | (313) | (393) | (336) | (289) | (343) | (279) | (352) | (395) | (402) | | (426) |
| | | | | | | | | | | | |
Operating Income | 97 | 127 | 294 | 332 | 458 | 651 | 751 | 1,021 | 1,390 | 1,728 | | 1,847 |
% Revenue | 5.6% | 6.0% | 9.9% | 11.9% | 12.5% | 13.3% | 13.6% | 13.3% | 12.8% | 13.2% | | 13.6% |
| | | | | | | | | | | | |
Interest Expense | 8 | 8 | 10 | 25 | 31 | 29 | 33 | 54 | 52 | 75 | | 89 |
Pre-tax Income | 106 | 135 | 303 | 357 | 489 | 680 | 784 | 1,074 | 1,442 | 1,803 | | 1,936 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (28) | (37) | (94) | (101) | (131) | (193) | (189) | (270) | (342) | (452) | | (481) |
Net Income to Company | 78 | 98 | 210 | 256 | 358 | 486 | 595 | 804 | 1,100 | 1,352 | | 1,455 |
% Margin | 4.5% | 4.6% | 7.1% | 9.1% | 9.8% | 10.0% | 10.8% | 10.4% | 10.1% | 10.4% | | 10.7% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 3 | (0) | (4) | (6) | (6) | (2) | (6) | (9) | | (11) |
Net Income to Stockholders | 78 | 98 | 213 | 255 | 354 | 481 | 589 | 802 | 1,094 | 1,343 | | 1,444 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 78 | 98 | 213 | 255 | 354 | 481 | 589 | 802 | 1,094 | 1,343 | | 1,444 |
% Margin | 4.5% | 4.6% | 7.2% | 9.1% | 9.7% | 9.8% | 10.7% | 10.4% | 10.0% | 10.3% | | 10.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.02 | 0.03 | 0.06 | 0.08 | 0.11 | 0.15 | 0.18 | 0.24 | 0.33 | 0.41 | | 0.44 |
Diluted EPS (Continuing Ops) | 0.02 | 0.03 | 0.06 | 0.08 | 0.11 | 0.15 | 0.18 | 0.24 | 0.33 | 0.41 | | 0.44 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 3,282.54 | 3,283.53 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | | 3,285.37 |
WA Diluted Shares Out. | 3,282.54 | 3,283.53 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | 3,286.86 | | 3,285.37 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 106 | 135 | 303 | 357 | 489 | 680 | 784 | 1,074 | 1,442 | 1,803 | | 1,936 |
Addback: Net Interest Expense | (8) | (8) | (10) | (25) | (31) | (29) | (33) | (54) | (52) | (75) | | (89) |
Addback: Other Non Operating Expenses, Total | (0) | (0) | (0) | (0) | (0) | (14) | 16 | (6) | (12) | (22) | | (23) |
Addback: Depreciation & Amortization | 11 | 18 | 14 | 13 | 13 | 14 | 13 | 20 | 31 | 37 | | 39 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | (4) | (3) | 0 | (6) | (4) | (2) | 4 | 2 | 4 | 10 | | 13 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 26 | (31) | 0 | 0 | 0 | (15) | (3) | (3) | 1 | | 3 |
Adjusted EBITDA | 105 | 167 | 290 | 339 | 467 | 649 | 769 | 1,032 | 1,410 | 1,754 | | 1,879 |
% Margin | 6.0% | 7.8% | 9.8% | 12.1% | 12.7% | 13.3% | 14.0% | 13.4% | 12.9% | 13.4% | | 13.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 93 | 149 | 275 | 327 | 454 | 635 | 756 | 1,012 | 1,379 | 1,717 | | 1,840 |
% Margin | 5.4% | 7.0% | 9.3% | 11.7% | 12.4% | 13.0% | 13.7% | 13.2% | 12.7% | 13.2% | | 13.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 78 | 98 | 210 | 256 | 358 | 486 | 595 | 804 | 1,100 | 1,352 | | 1,455 |
Addback: Unusual Items | (4) | 22 | (18) | (6) | (4) | (2) | (11) | (2) | 1 | 11 | | 16 |
Less: Tax Benefit of Unusual Items (26%) | 1 | (6) | 5 | 2 | 1 | 1 | 3 | 0 | (0) | (3) | | (4) |
Adjusted Net Income | 75 | 114 | 196 | 252 | 355 | 485 | 587 | 803 | 1,101 | 1,360 | | 1,467 |
% Margin | 4.3% | 5.4% | 6.7% | 9.0% | 9.7% | 9.9% | 10.7% | 10.4% | 10.1% | 10.4% | | 10.8% |